HIRECT
Hind Rectifiers Limited
Each stock's 10,000-path forecast, rendered as light.
Hind Rectifiers Limited (HIRECT) Stock Analysis & Case Study
Is HIRECT a good buy? The data-driven verdict.
Hind Rectifiers Limited (HIRECT) trades at ₹1,310,on the numbers it mixed signals, a Downstox Snapshot Score of 47/100.
On the numbers, Hind Rectifiers Limited (HIRECT) mixed signals, a Downstox Snapshot Score of 47/100, weighing expensive at 100.0× earnings, ROE of 25.2%, a 48% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
HIRECT fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How HIRECT ranks against the 2,373 companies in our screener
- HIRECT's market cap of 4,646 Cr ranks in the 65th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HIRECT's book value of ₹61 ranks in the 38th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HIRECT's promoter holding of 42.6% ranks in the 19th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HIRECT's 3-year profit (PAT) growth of 100.0% ranks in the 94th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HIRECT's 3-year revenue growth of 100.0% ranks in the top 3% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HIRECT's debt-to-equity ratio of 1.17x is lower than 11% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is HIRECT overvalued? HIRECT P/E vs peers
HIRECT trades at 100.0× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
HIRECT share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of HIRECT history (35%/yr drift, 58%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| HIRECT 2027 | ₹599 | ₹1,265 | ₹2,674 | -3% |
| HIRECT 2028 | ₹430 | ₹1,222 | ₹3,474 | -7% |
| HIRECT 2029 | ₹332 | ₹1,180 | ₹4,186 | -10% |
| HIRECT 2030 | ₹259 | ₹1,139 | ₹5,007 | -13% |
| HIRECT 2031 | ₹208 | ₹1,100 | ₹5,807 | -16% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability HIRECT goes up, or doubles?
The bull case for HIRECT
- HIRECT's return on equity of 25.2% ranks in the 90th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- HIRECT's return on capital employed of 18.8% ranks in the 77th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹4,186.
The bear case & risks
- HIRECT's P/E of 100.0x is lower than 11% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A steep 21.6× price-to-book means most of the value is intangible/expectations, not assets on the books.
- High historical volatility (58%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹332.
HIRECT volatility & expected range, how bumpy is the ride?
Over the last 9.8 years HIRECT compounded at 35%/year with annualized volatility of 58%. That volatility implies a 1-year 80% range of ₹599-₹2,674, the honest backbone behind any single price target.
HIRECT price forecast, the full 60-month probability fan
HIRECT price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds HIRECT hits common targets within the simulated horizon?
Full multi-horizon detail on the HIRECT price target & forecast page.
HIRECT Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. HIRECT scores 5/8, mixed financial health.
HIRECT MTF margin & leverage across 9 brokers
Margin Trading Facility lets you buy HIRECT with part of the capital. Lower margin % = higher leverage. Rates compared across 9 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 42.17% | 2.4× |
| ZerodhaCHEAPEST | 42.11% | 2.4× |
| Groww | 42.40% | 2.4× |
| Dhan | 50.00% | 2.0× |
| Kotak Neo | 100.00% | 1.0× |
| Paytm Money | 42.87% | 2.3× |
| Pocketful | 42.95% | 2.3× |
| Anand RathiCHEAPEST | 42.11% | 2.4× |
| Share India | 42.33% | 2.4× |
Compare every broker on the HIRECT MTF page.
About Hind Rectifiers Limited: sector, index & market-cap context
Hind Rectifiers Limited (HIRECT) is a small-cap NSE-listed company, with a market capitalisation of ₹4,646 Cr. See more stocks on our screener.
How the HIRECT Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Hind Rectifiers Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
HIRECT analysis, FAQs
Is Hind Rectifiers Limited (HIRECT) a good buy?
On the numbers, Hind Rectifiers Limited (HIRECT) mixed signals, a Downstox Snapshot Score of 47/100, weighing expensive at 100.0× earnings, ROE of 25.2%, a 48% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is HIRECT overvalued or undervalued?
HIRECT trades at 100.0× earnings, expensive versus the ~22× long-run Nifty average.
What is the HIRECT share price target for 2031?
HIRECT's probability-weighted 2031 median target is ₹1,100, with an 80% range of ₹208-₹5,807 (10,000-path Monte-Carlo).
What is the probability HIRECT doubles in 5 years?
The modelled probability of HIRECT reaching ₹2,620 (2×) within 5 years is 25%.
What is the bull case for HIRECT?
HIRECT's return on equity of 25.2% ranks in the 90th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. HIRECT's return on capital employed of 18.8% ranks in the 77th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in HIRECT?
HIRECT's P/E of 100.0x is lower than 11% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A steep 21.6× price-to-book means most of the value is intangible/expectations, not assets on the books. High historical volatility (58%/yr) means a wide, bumpy range of outcomes, size positions accordingly.